Institutional
Sanofi (SNY, SNYNF)
CIK 0001121404
$534.0M
Reported AUM
10
Positions
Q2 2026
Period
2026-07-28
Filed
Editorial summary
Summary for Sanofi (SNY, SNYNF) · Q2 2026 is not yet generated. It will appear here after the next nightly run.
Portfolio · Q2 2026
Top holdings
| # | Stock | Issuer | Price | Day % | 1Y Gr. | 5Y Gr. | Value | % of book | Δ shares (QoQ) | Status |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | MGTX | MeiraGTx Holdings plc | $11.98 | 3.10% | 56.60% | -4.24% | $164.8M | 30.86% | — | HELD |
| 2 | INBX | Inhibrx Biosciences, Inc. | $84.73 | 6.91% | 292.27% | 497.95% | $109.7M | 20.54% | — | HELD |
| 3 | NVAX | Novavax | $7.44 | 1.36% | 13.41% | -96.88% | $64.8M | 12.14% | — | HELD |
| 4 | ANAB | AnaptysBio | $55.04 | 5.56% | 224.54% | 212.89% | $55.5M | 10.39% | — | HELD |
| 5 | ODTX | Odyssey Therapeutics Inc. | $18.42 | 2.05% | 12.18% | -1.55% | $37.3M | 6.98% | — | HELD |
| 6 | AGMB | Agomab Therapeutics NV | $12.76 | 2.90% | -12.94% | 21.59% | $36.1M | 6.76% | — | HELD |
| 7 | MPLT | MapLight Therapeutics Inc. | $14.03 | -6.59% | -14.57% | 6.05% | $32.7M | 6.12% | — | HELD |
| 8 | TRAX | First Tracks Biotherapeutics Inc. | $47.78 | 14.12% | 103.32% | 199.37% | $16.5M | 3.10% | — | HELD |
| 9 | IMRX | Immuneering Corp | $4.23 | 4.32% | 25.52% | -82.71% | $13.5M | 2.53% | — | HELD |
| 10 | QTTB | Q32 Bio Inc. | $15.56 | 6.28% | 635.25% | -88.64% | $3.1M | 0.58% | — | HELD |
Source: SEC EDGAR · accession 0001193125-26-318812. 13F discloses long positions only — shorts, foreign equities, and options are excluded.